3 news items
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
FOLD
9 May 24
on Galafold use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. Advise women of the potential risk to a fetus
WuXi Biologics Reports Solid 2023 Annual Results
BNTX
FOLD
GSK
26 Mar 24
and Governance (ESG) as an essential part of its sustainable business growth strategies. The Group's ESG performance has been evaluated by major ESG rating
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
FOLD
28 Feb 24
year of non-GAAP profitability. Amicus is at a major inflection point and strongly positioned to continue to advance our mission of delivering
- Prev
- 1
- Next